Keywords: ligand, earns, million, milestone, drugmaker, medarex, says

Ligand earns $1.5 million milestone

Article | 23 July 2007

US drugmaker Medarex says that Swiss drug major Novartis has advanced ACZ885, their co-developed fully-human anti-interleukin-1 beta antibody drug candidate, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing